Statin prescribing among hypertensive patients in southwest Nigeria: Findings and implications for the future

Onyinye Onyeka Akunne, Brian Godman*, Aduragbenro Deborah Adedapo, Ilse Truter, Joseph Fadare

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Background: Statins reduce cardiovascular risk, especially in patients with hypertension due to their concomitant blood pressure reducing effects. Prescribing generic statins minimizes cost and improves access. Aims: Ascertain current prescribing of statins in Nigeria and potential savings from the increased use of generic statins. Methods: Prospective study involving hypertensive patients attending University College Hospital (Ibadan, Nigeria). Results: In total, 228 hypertensive patients received statins. Atorvastatin was the most prescribed statin, followed by simvastatin, rosuvastatin and finally fluvastatin. Prescribed doses were less than one defined daily dose in the majority, with high use of originators. Average monthly potential savings from increased prescribing of generic statins was US$2635 for atorvastatin and US$10,578 for rosuvastatin. Conclusion: A shift toward increased prescribing generic statins is recommended to minimize costs.

Original languageEnglish
Pages (from-to)281-288
Number of pages8
JournalJournal of Comparative Effectiveness Research
Volume5
Issue number3
DOIs
Publication statusPublished - May 2016
Externally publishedYes

Keywords

  • Nigeria
  • costs
  • generics
  • hypertension
  • statins

Fingerprint

Dive into the research topics of 'Statin prescribing among hypertensive patients in southwest Nigeria: Findings and implications for the future'. Together they form a unique fingerprint.

Cite this